Diseases activity and lipids in rheumatoid arthritis: A prospective study

Indian Journal of Rheumatology

Volumn 2, Issue 4, 2007, Pages 137-140

  Hadda, V ^a   Handa, Rohini ^a   Aggarwal, P ^a   Lakshmy, R ^a   Kumar, U ^a   Pandey, R M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asian Indians; Disease activity; Dyslipidemia; RA

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID DERIVATIVE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DISEASE ACTIVITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; INDIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84992281729     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0973-3698(10)60057-X     Document Type: Article

References (13)

1. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "High-Grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
2. Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE, et al. Influence of glucocorticoid and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62: 842-5.
3. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1701-4.
4. Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 172-8.
5. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidemias in urban slum population in northern India. Int J Obes Relat Metab Disord 2001; 25: 1722-9.
6. Vottery R, Saigal R, Singhal N, Gupta BS. Lipids profile and its relation to disease activity. J Assoc Physician India 2001; 49: 1188-90.
7. Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R. Subclinical atherosclerosis in RA. Ind J Rheumatol 2006; 33: 244-7.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
9. Preevoo ML, von't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PL. Modified disease activity score that include twenty eight joint counts: development and validation in a prospective longitudinal study of patients with RA. Arthritis Rheum 1995; 38: 44-8.
10. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285: 2486-97.
11. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-6.
12. Vijayakumar D, Suresh K, Manoharan S. Altered pattern of lipids in plasma and erythrocyte membranes of rheumatoid arthritis patients. Ind J Clin Biochem 2005; 20: 52-5.
13. Munro R, Morrison E, McDonald AG, Hunter JA, Madhok R, Capell HA. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis 1997; 56: 374-7.